A Quebec publishing controversy has escalated after Les Éditions du Boréal confirmed that artificial intelligence was used during the writing of Thélyson Orélien’s novel C’était ça ou mourir. The publisher said it will not reprint the book or publish any further works by the author.
The decision marks a sharp reversal from the publisher’s position one week earlier, when it said there was not enough evidence to establish conclusively that AI had been used. The case has prompted renewed debate across the French-language publishing industry about disclosure, authorship and trust.
Publisher confirms AI was used in the writing process
In a statement issued on Wednesday 21 October, Boréal said new information confirmed in recent days that artificial intelligence had been involved in the novel’s writing process.
The publisher said this contradicted assurances previously given by Orélien, who had maintained that he had not used AI to create the book. Boréal did not state precisely how much of the novel was generated or shaped by artificial intelligence.
Instead, the publishing house emphasised that the central issue was its relationship of trust with the author. It said the uncertainty surrounding the extent of AI involvement meant that a definitive answer might never be available.
- The novel: C’était ça ou mourir
- Author: Thélyson Orélien
- Publisher: Les Éditions du Boréal
- Publisher’s decision: No reprint and no future books by the author
- Outstanding question: The precise extent of AI use remains unclear
External analysis examined the novel’s working versions
Boréal said it commissioned an independent, in-depth analysis of all available working versions of the novel after doubts intensified. The review followed the author’s announcement that he would not provide additional material for examination.
That decision left the publisher facing a difficult distinction: evidence could indicate that AI had been used, while still failing to establish exactly which passages, drafts or stages of the writing process were affected.
The publisher’s response therefore focuses less on proving a precise percentage of machine-generated text and more on whether the author’s previous statements were reliable. That approach reflects a broader concern in publishing, where contracts and editorial relationships depend heavily on confidence in an author’s representations.
How the controversy began
The dispute emerged after the X account “Balance ton Claude” accused the novel of containing extensive AI-generated material. The allegations circulated widely and placed the book and its author under sustained scrutiny.
At first, Boréal said it was supporting Orélien because it lacked evidence that could establish AI use with certainty. The publisher’s subsequent decision followed further information and the external assessment of the manuscript’s development materials.
The episode illustrates the difficulty of investigating AI-assisted writing after publication. Text-analysis tools may identify patterns associated with automated generation, but determining how a work was actually produced often requires access to drafts, notes, prompts and correspondence. Those materials may be incomplete or unavailable.
Why the case matters for French-language publishing
The dispute has become a significant cultural story because it raises questions that extend beyond one book. Publishers, authors and readers are increasingly having to define what forms of AI assistance are acceptable and when they should be disclosed.
Possible uses of AI can range from spelling correction and translation support to brainstorming, rewriting or generating complete passages. These activities do not carry the same implications for authorship, but publishing agreements may not always distinguish them clearly.
The case highlights several unresolved issues:
- What level of AI assistance should be disclosed to a publisher?
- Should contracts define whether generative AI may be used at any stage?
- How can publishers assess allegations without relying solely on automated detection tools?
- What information should readers receive about the creation of a literary work?
- How should responsibility be allocated when an author’s statements conflict with later findings?
These questions are particularly sensitive in literary fiction, where originality, voice and individual creative expression are central to the value of the work. They also affect translators, editors, illustrators and other professionals whose contributions may be altered or replaced by generative systems.
A publishing decision rather than a legal ruling
Boréal’s announcement is a contractual and commercial decision by a private publisher. It is not a court judgment or a finding by a public regulator. The statement also did not establish the precise scale of AI involvement or indicate that every part of the novel was generated by a machine.
This distinction matters because allegations of undisclosed AI use can have serious professional consequences, while the available evidence may not answer every factual question. In this case, the publisher said the loss of trust was sufficient to end its relationship with the author, even though the extent of AI assistance remains uncertain.
What happens next?
Boréal has said it will not produce another print run of C’était ça ou mourir and will not publish further books by Orélien. The publisher’s statement did not provide additional details about the book’s availability, existing contracts or any possible response from the author.
The wider debate is likely to continue as publishing houses develop policies for generative AI. Clearer contractual language may become increasingly important, particularly around disclosure, manuscript provenance and the use of AI in editing or drafting.
Conclusion
The Quebec publishing controversy shows how artificial intelligence is challenging long-standing assumptions about literary authorship. Although the exact extent of AI use in C’était ça ou mourir remains unresolved, Les Éditions du Boréal has concluded that its trust in the author has been damaged. The case may encourage publishers to demand clearer disclosure and stronger documentation of how manuscripts are created.